January 22, 2025
French-based private equity firm Lauxera Capital invests in German neurovascular device firm Acandis to drive growth and U.S. expansionPress Release/NKP | M&A Insights Proprietary
June 24, 2024
Update: NBOs are due Friday in the Benten Capital advised sales process for Acandis, expected to generate EUR 60m in revenues in 2024E (NKP Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights
May 29, 2024
Acandis, a founder-owned provider of German-produced minimally invasive endovascular technologies, primarily stents for, treating and preventing strokes, is pursuing a growth equity round advised by Benten Capital, according to several sources (NKP Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights
.png){kind=logo}